Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function
Greenfield RA, Gerber AU, Craig WA (1983) Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function. Rev Infect Dis S127-S136
Fernandez-Torre JL, Martinez-Martinez M, Gonzalez-Rato J, Maestro I, Alonso I, Rodrigo E, Horcajada JP (2005) Cephalosporin- induced nonconvulsive status epilepticus: Clinical and electroencephalographic features 46:1550-1552
The neurotoxicity and safety of treatment with cefepime in patients with renal failure
DOI 10.1093/ndt/gfm713
Sonck J, Laureyes G, Verbeelen D (2008) The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Nephrol Dial Transplant 23:966-970 (Pubitemid 351767571)
Cefepime and cefixine-induced encephalopathy in a patient with normal renal function
Capparelli FJ, Diaz MF, Hlavnika A, Wainsztein NA, Leiguarda R, Del Castillo ME (2005) Cefepime and cefixine-induced encephalopathy in a patient with normal renal function. Neurology 65:1840
Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats
De Sarro DA, Ammendola D, Zappala M et al (1995) Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats. Antimicrob Agents Chemother 39:232-237
Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy
Eggers V, Fugener K, Hein OV et al (2004) Antibiotic-mediated release of tumor necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy. Intensive Care Med 30:1544-1551 (Pubitemid 39094954)